Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Expression Level of Translocator Protein (TSPO) and Binding Activity in Normal Cutaneous Tissue Versus Non Melanotic Cutaneous Malignancy.

NCT01265472 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01265472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Expression Level of Translocator Protein (TSPO) and Binding Activity in Normal Cutaneous Tissue Versus Non Melanotic Cutaneous Malignancy.
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
July 31, 2011
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, squamous cell carcinoma